×

All day rhinitic condition treatment regimen

  • US 20080015241A1
  • Filed: 07/13/2006
  • Published: 01/17/2008
  • Est. Priority Date: 07/13/2006
  • Status: Abandoned Application
First Claim
Patent Images

1. A therapeutic regimen comprising:

  • a first pharmaceutical dosage form comprising a first therapeutically effective amount of a first antihistamine having H1 receptor activity and a therapeutically effective amount of an anticholinergic;

    a second pharmaceutical dosage form comprising a second therapeutically effective amount of a second antihistamine having H1 receptor activity and a therapeutically effective amount of the anticholinergic, wherein the second antihistamine H1 receptor activity is greater than the first antihistamine H1 receptor activity, with the proviso that the second antihistamine is not acrivastine, astemizole, cetirizine, loratadine, mizolastine, desloratidine or fexofenadine;

    indicia for distinguishing between the first and second pharmaceutical dosage forms;

    wherein the indicia distinguishes the first pharmaceutical dosage form for daytime administration and the second pharmaceutical dosage form for nighttime administration; and

    a prepackaged dispenser prefilled with the pharmaceutical dosage forms and comprising the indicia.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×